The Solitaire FR device, from Covidien (NYSE:COV) is used to restore blood flow to the brain in patients suffering acute ischemic stroke. The company received regulatory approval in Brazil for the device on July 19th.
Home » Covidien’s Solitaire FR Revascularization Device Receives Regulatory Approval in Brazil